covid
Buscar en
Gaceta Médica de Bilbao
Toda la web
Inicio Gaceta Médica de Bilbao S3.4 Manejo terapéutico del síndrome de boca ardiente
Información de la revista
Vol. 98. Núm. 4.
Páginas 111-112 (enero 2001)
Compartir
Compartir
Descargar PDF
Más opciones de artículo
Vol. 98. Núm. 4.
Páginas 111-112 (enero 2001)
Acceso a texto completo
S3.4 Manejo terapéutico del síndrome de boca ardiente
S3.4 Treatment of burning mouth syndrome
Visitas
1968
P.J. Lamey
Universidad de Belfast. Irlanda del Norte
Este artículo ha recibido
Información del artículo
El Texto completo está disponible en PDF
References
[1.]
Bergdahl M., Bergdahl J..
Burning mouth syndrome: prevalence and associated factors.
J Oral Pathol Med, 28 (1999), pp. 350-354
[2.]
Lamey P.J., Lamb A.B..
Lip component of burning mouth syndrome.
Oral Surg Oral Med Oral Pathol, 78 (1994), pp. 590-593
[3.]
Freeman R..
A psychotherapeutic case illustrating a psychogenic factor in burning mouth syndrome.
Br J Psychotherapy, 10 (1993), pp. 220-225
[4.]
Lamey P.J., Lamb A.B., Hughes A., Milligan K.A., Forsyth A..
Type 3 burning mouth syndrome: psychological and allergic aspects.
J Oral Pathol Med, 23 (1994), pp. 216-219
[5.]
Lamey P.J..
Burning mouth syndrome.
Dermatol Clin, 14 (1996), pp. 339-354
[6.]
Lamey P.J., Lamb A.B..
Prospective study of aetiological factors in burning mouth syndrome.
BMJ, 296 (1988), pp. 1243-1246
[7.]
Grushka M., Sessie B.J., Miller R..
Pain and personality profiles in burning mouth syndrome.
Pain, 28 (1987), pp. 155-167
[8.]
Browning S., Hislop S., Scully C., Shirlaw P..
The association between burning mouth syndrome and psychological disorders.
Oral Surg Oral Med Oral Pathol, 64 (1987), pp. 171-174
[9.]
Lamb A.B., Lamey P.J., Reeve P.E..
Burning mouth syndrome: psychological aspects.
Br Dent J, 165 (1998), pp. 256-260
[10.]
Lamey P.J., Lamb A.B..
The usefulness of the HAD scale in assessing anxiety and depression in patients with burning mouth syndrome.
Oral Surg Oral Med Oral pathol, 67 (1989), pp. 390-392
[11.]
Carlson C.R., Miller C.S., Reid K.I..
Psychosocial profiles of patients with burning mouth syndrome.
J Orofac Pain, 14 (2000), pp. 59-64
[12.]
Humphris G.M., Longman I.P., Field E.A..
Cognitive-behavioural therapy for idiopathic burning mouth syndrome: a review of two cases.
Br Dent J, 181 (1996), pp. 204-208
[13.]
Bogetto F., Maina G., Ferro G., Carbone M., Gandolfo S..
Psychiatric comorbidity in patients with burning mouth syndrome.
Psychosom Med, 60 (1998), pp. 378-385
[14.]
Svensson P., Bjerring P., Arendt-Nielsen L., Kaaber S..
Sensory and pain thresholds to orofacial argon laser stimulation in patients with chronic Burning mouth syndrome.
Clin J Pain, 9 (1993), pp. 207-215
[15.]
Lamey P.J., Hobson R.S., Orchardson R..
Perception of stimulus size in patients with burning mouth syndrome.
J Oral Pathol Med, 25 (1996), pp. 420-423
[16.]
Formaker B.K., Frank M.E..
Taste function in patients with oral burning.
Chem Senses, 25 (2000), pp. 575-581
[17.]
Lundy F.T., Al-Hashimi I., Rees T.D., Lamey P.J..
Evaluation of major parotid glycoproteins in patients with burning mouth syndrome.
Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 83 (1997), pp. 252-258
[18.]
Mizukawa N., Sugiyama K., Ueno T., Mishima K., Takagi S., Sugahara T..
Defensin-1, an antimicrobial peptide present in the saliva of patients with oral diseases.
Oral Dis, 5 (1999), pp. 139-142
[19.]
Lamey P.J., Murray B.M., Eddie S.A., Freeman R.E..
The secretion of parotid saliva as stimulated by 10% citric acid is not related to precipitating factors in burning mouth syndrome.
J Oral Pathol Med, 30 (2001), pp. 121-124
[20.]
Bessho K., Okubo Y., Hori S., Murakami K., lizuka T..
Effectiveness of kampo medicine (sai-boku-to) in treatment of patients with glossodynia.
Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 86 (1998), pp. 682-686
[21.]
Tammiala-Salonen T., Forssell H..
Trazodone in burning mouth pain: a placebo-controlled, double-blind study.
J Orofac Pain, 13 (1999), pp. 83-88
[22.]
Femiano F., Gombos F., Scully C., Busciolamo M., Luca P.D..
Burning mouth syndrome (BMS): controlled open trial of the efficacy of alpha-lipoic acid (thioctic acid) on symptomatology.
Oral Dis, 6 (2000), pp. 274-277
[23.]
Brown R.S., Krakow A.M., Douglas T., Choksi S.K..
Scalded mouth syndrome” caused by angiotensin converting enzyme inhibitors: two case reports.
Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 83 (1997), pp. 665-667
[24.]
Clifford T.J., Warsi M.J., Burnett C.A., Lamey P.J..
Burning mouth in Parkinson's disease sufferers.
Gerodontology, 15 (1998), pp. 73-78
[25.]
Heckmann S.M., Heckmann J.G., Hilz M.J., Popp M., Marthol H., Neundorfer B., Hummel T..
Oral mucosal blood flow in patients with burning mouth syndrome.
Pain, 90 (2001), pp. 281-286
[26.]
Lamey P.J., Lamb A.B..
Refractory Burning Mouth Syndrome in Non-res-ponders in Gastroenterology.
pp. 3-25
[27.]
Engman M.F..
Burning tongue.
Arch Dermatol Syphil, 1 (1920), pp. 137-138
[28.]
Berghahl J., Anneroth G..
Burning mouth syndrome: literature review and model for research and management.
J Oral Pathol Med, 22 (1993), pp. 433-438
Copyright © 2001. Academia de Ciencias Médicas de Bilbao
Descargar PDF
Opciones de artículo